LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells $470,564.29 in Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Kevin Michael Mullins sold 85,093 shares of LifeStance Health Group stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $5.53, for a total value of $470,564.29. Following the completion of the sale, the insider now directly owns 4,650,571 shares in the company, valued at approximately $25,717,657.63. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

LifeStance Health Group Trading Down 2.6 %

Shares of LifeStance Health Group stock opened at $5.28 on Friday. The company has a market capitalization of $2.02 billion, a price-to-earnings ratio of -11.00 and a beta of 1.23. The business has a fifty day simple moving average of $6.19 and a two-hundred day simple moving average of $6.59. LifeStance Health Group, Inc. has a 1 year low of $4.74 and a 1 year high of $9.59. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.18 and a quick ratio of 1.18.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Thursday, May 9th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.03. The company had revenue of $300.44 million for the quarter, compared to analyst estimates of $299.02 million. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. The firm’s quarterly revenue was up 18.9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.09) earnings per share. Research analysts forecast that LifeStance Health Group, Inc. will post -0.27 EPS for the current year.

Institutional Investors Weigh In On LifeStance Health Group

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Sunbelt Securities Inc. bought a new position in LifeStance Health Group during the third quarter worth about $34,000. DekaBank Deutsche Girozentrale acquired a new position in shares of LifeStance Health Group during the 3rd quarter worth approximately $34,000. Bessemer Group Inc. increased its holdings in shares of LifeStance Health Group by 43.4% during the first quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock worth $56,000 after purchasing an additional 2,768 shares during the period. Allen Investment Management LLC bought a new stake in shares of LifeStance Health Group in the first quarter valued at approximately $79,000. Finally, Stratos Wealth Partners LTD. acquired a new stake in LifeStance Health Group during the fourth quarter worth approximately $93,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on LFST. Jefferies Financial Group boosted their price target on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Barclays boosted their target price on shares of LifeStance Health Group from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Thursday, February 29th. Morgan Stanley reiterated an “overweight” rating and issued a $10.00 price target on shares of LifeStance Health Group in a research note on Monday, April 22nd. Finally, The Goldman Sachs Group boosted their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a research note on Monday, March 4th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $8.80.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.